Kasper Dreyer, Ph.D. Email and Phone Number
Experienced drug developer with strong business background. Very passionate about energizing and growing professionals to excel and innovate. Strategic thinker with superior analytical skills to ask the right questions and courage to deliver tough answers.Broad base of 20 years past experiences- Trained in blue chip Pharma and work in fast paced small biotech- Hands on from pre-clinical, through Ph1-Ph3, Registration and Launch prep- Developed Cardiovascular, Metabolism, Immunology and Oncology drugs- Done Strategic Partnerships, Alliances, Outsourcing and contracting- Worked in both Innovator and Generics businesses
-
Vice President Of Lifecycle Management And Basel Site HeadIronwood Pharmaceuticals Aug 2024 - PresentBoston, Ma, Us
-
Head Of Global Program Management, Vice PresidentPharvaris Jun 2022 - Apr 2024Zug, ChHeaded Program Office with 4 PMs supporting, tracking and reporting on drug and non-drug projects across Pharvaris.Lead Pharvaris' 2 main development programs incl. Ph2 to Ph3 transition with HA aligned Ph3 design and strategy.Delivered new Line Extension business case endorsed by Board. -
Global Program HeadSandoz May 2020 - Jul 2022Basel, Basel-Stadt, ChGlobal Head of 2 Oncology and 1 Immunology biosimilar development programs.Delivered Ph3 completion, regulatory filing strategy and submission of high quality dossiers to FDA & EMA.Sandoz’ Steering Committee member for two partnership program. -
Global Program HeadNovartis Mar 2016 - May 2020Basel, Baselstadt, ChOverall responsible for $300m Development Program - Team, Strategy and Execution• Led clinical study with ~100 FTEs in 39 countries and >10,000 patients enrolled to successful completion• Developed and drove bold submission strategy recognizing evolving market conditions• Ensured high quality regulatory filings and led global team through US and RoW registration processes• Co-led launch preparations with Brand Director• Early pipeline GPH – driving decisions on acceleration and termination of research assets -
Senior Global Program Team DirectorNovartis May 2014 - Mar 2016Basel, Baselstadt, Ch• Successfully sustained high performing global program team over a 6 year phase III study• Oversight of all line function deliverables - Clinical dev plan, IB, integrated product strategy, Value Dossier, etc• Budget responsible for $50mio annual program budget• Due Diligence leader
-
Global Program Team DirectorNovartis Mar 2011 - Apr 2014Basel, Baselstadt, Ch• Led global program team through initiation of major clinical phase III study across 39 countries, incl. JP & CN• Drove numerous clinical and commercial indication expansion evaluations• Facilitated improved clinical operations and productivity savings of ~35 mUSD
-
Senior Portfolio ManagerNovartis Oct 2009 - Mar 2011Basel, Baselstadt, Ch• Developed new portfolio prioritization framework for Global Development; eliminating resourcing inefficiencies• Revamped portfolio management in Cardiometabolic Development Unit to support portfolio trade-off decisions• Only portfolio manager nominated as core member of a Franchise Mgmt Board
-
Global Portfolio ManagerNovo Nordisk A/S Apr 2007 - Sep 2009Bagsværd, DkPartner and challenger for program teams approaching significant governance milestones• Achieved >80% of recommendations made to governance boards endorsed, incl. terminations• Market Research and BD&L evaluations -
Portfolio AnalystNovo Nordisk A/S Nov 2003 - Mar 2007Bagsværd, Dk• Conducted 100+ ENPVs - proficiency in forecasting, market assessments, price & access, cannibalization, manufacturing facility investments and terms sheets.• Authored Novo Nordisk’s Development Project Manual• Achieved ISO certification through SOP and Governance process optimization
-
Research ScientistCombio A/S Jan 2002 - Oct 2003Research Scientist and Project Manager in Drug Discovery.- Assay development in proprietary high throughput screening- Enzyme kinetics- Recombinant protein production, purification and characterisation- Primary cell culture assays
Kasper Dreyer, Ph.D. Education Details
-
Aarhus UniversityMolecular Biology -
Copenhagen Business SchoolStrategic Management And Corporate Development
-
University Of BaselSwitzerland
-
Aarhus UniversityChemistry-Biotechnology
Frequently Asked Questions about Kasper Dreyer, Ph.D.
What company does Kasper Dreyer, Ph.D. work for?
Kasper Dreyer, Ph.D. works for Ironwood Pharmaceuticals
What is Kasper Dreyer, Ph.D.'s role at the current company?
Kasper Dreyer, Ph.D.'s current role is Vice President of Lifecycle Management and Basel Site Head.
What schools did Kasper Dreyer, Ph.D. attend?
Kasper Dreyer, Ph.D. attended Aarhus University, Copenhagen Business School, University Of Basel, Aarhus University.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial